Dr Angela Jia Outlines Decisions on Treatment or Observation in Prostate Cancer
May 7th 2024Risk factors and prostate-specific antigen are both important when determining how to move forward with treatment, explained Angela Jia, MD, PhD, of University Hospitals and Case Western Reserve University School of Medicine.
Read More
Recent Advancements Have Disrupted the Field of Bladder Cancer, Says Dr Alexander Kutikov
May 7th 2024There are increasingly more bladder-sparing strategies for patients with even aggressive bladder cancer, said Alexander Kutikov, MD, FACS, chair, Department of Urology, Fox Chase Cancer Center.
Read More
Mary Dunn: We’ve Come a Long Way in Treatment for Urologic Cancers
May 6th 2024With more therapies available in bladder, kidney, and prostate cancers, collaboration among health care providers can help ensure patients are getting the most appropriate care for their type and stage of cancer, said Mary Dunn, MSN, NP-C, OCN, RN, of University of North Carolina.
Read More
Dr Joshua Meeks on the Benefits, Challenges of Many Options to Treat Bladder Cancer
May 6th 2024There are many options to try for patients if one therapy doesn’t work, but there are challenges around getting new treatments into the clinic, said Joshua Meeks, MD, PhD, of Northwestern University Feinberg School of Medicine.
Read More
Identifying Good Candidates for Active Surveillance of Kidney Cancer
May 5th 2024Patients with small or slow-growing tumors or those with comorbidities that make them higher risk are likely better candidates for active surveillance, explained Yuzhi Wang, MD, of Henry Ford Health Vattikuti Urology Institute.
Read More
Advancements in Bladder Cancer Treatment Require Multidisciplinary Team Care
May 5th 2024Evolving treatment for bladder cancer is going to require a multidisciplinary team to ensure patients are receiving optimal care, said Neal D. Shore, MD, FACS, medical director of the Carolina Urologic Research Center.
Read More